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Abstract  
Head and neck cancer (HNC) is the sixth most common malignancy worldwide. 
Squamous cell carcinoma, the primary cause of HNC, evolves from normal epithelium 
through dysplasia before invading the connective tissue to form a carcinoma. 
However, less than 18% of suspicious oral lesions progress to cancer with diagnosis 
currently relying on histopathological evaluation, which is invasive and time 
consuming. A non-invasive, real-time, point-of-care method could overcome these 
problems and facilitate regular screening. Raman spectroscopy can non-invasively 
provide information regarding the biochemical composition of tissues. In this study, 
Raman Spectroscopy was assess d for its ability to discriminate between normal, pre-
malignant and head and neck squamous cell carcinoma (HNSCC). Tissue engineered 
models of normal, dysplastic and HNSCC were constructed using normal oral 
keratinocytes, dysplastic and HNSCC cell lines and their biochemical content predicted 
by interpretation of spectral characteristics. Spectral features of normal models were 
mainly attributed to lipids, whereas, malignant models were observed to be protein 
dominant. Visible differences between the spectra of normal, dysplastic and cancerous 
models, specifically in the bands of amide I and III were observed. Normal mucosal 
models displayed a sharp and weak lipid peak at 1667cm
-1
 whereas HNSCC spectra 
showed a broad and strong amide I peak at this wavenumber. A shift at 2937cm
-1
 was 
only observed in DOK, differentiating them from the other tissue types. Multivariate 
data analysis algorithms successfully identified subtypes of dysplasia and cancer, 
suggesting that Raman spectroscopy can be used to discriminate between normal and 
malignant tissues.   
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Key words: Tissue engineering, oral mucosa, Raman spectroscopy, squamous cell 
carcinoma, diagnostics.  
1. Introduction 
Head and Neck cancer (HNC) is the sixth most common malignancy worldwide with 
approximately 500 000 new cases per year. Prognosis is poor with only a 50% 5 year 
survive rate (Johnson et al., 2011, Argiris et al., 2008). Squamous cell carcinoma, the 
primary cause of HNC, is typically preceded by pre-malignant, cellular abnormalities in 
the epithelium, called dysplasia. A dysplastic epithelium evolves through mild, 
moderate and severe stages before invading the connective tissue to form a carcinoma 
(Napier and Speight, 2008). The low survival rate can in part be attributed to the 
difficulty in diagnosing the disease at an early stage (Epstein et al., 2002). Currently, 
visual inspection of the oral cavity is the first line of diagnostic screening, followed by 
histopathological evaluation of biopsies that are surgically removed from any 
suspicious lesion. Although histopathological evaluation is at present the most 
accurate and reliable method for diagnosis it has several limitations. Surgical biopsies 
are invasive and take time to analyse, causing anxiety for patients as well as being 
time-consuming and causing delays in treatment (Stefanuto et al., 2014). The need for 
a scalpel biopsy also reduces the rate at which histopathological evaluation is 
performed and reduces the frequently of monitoring and screening of suspected 
lesions. Furthermore, histopathological analysis is associated with inter-observer 
variability (Reibel, 2003). For all these reasons it is clear that there is the need for a 
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non-invasive, real-time, point-of-care method to accurately detect and diagnose oral 
cancerous changes at an early stage. 
During cancer progression biochemical changes occur within cancer cells altering the 
levels of nucleic acids, proteins, lipids and carbohydrates and that may serve as 
potential markers for disease monitoring (Stone et al., 2002, Stone et al., 2004). 
Recently optical techniques such as elastic light scattering, fluorescence and Raman 
spectroscopy have been studied for their ability to characterize the biochemical 
makeup of biological tissues and therefore their potential as a non-invasive, diagnostic 
tool for cancer detection (Movasaghi et al., 2012). Among these Raman spectroscopy 
in particular has shown encouraging results for both the characterisation and 
detection of disease in different biological tissues including the gastrointestinal tract 
(Teh et al., 2010), breast tissue (Rehman et al., 2007), lungs (Short et al., 2011), larynx 
(Stone et al., 2000), testicular (Movasaghi et al., 2012) and head and neck including the 
oral cavity (Devpura et al., 2012, Valdés et al., 2014, Malini et al., 2006). Raman 
spectroscopy utilizes a technique of inelastic light scattering, which is characterised by 
a shift in the wavelength of incident light that occurs due to the specific molecular 
vibrations of the biological tissues. The Raman spectrum obtained can provide 
information regarding biochemical configuration and conformations related to the key 
biological components of tissues i.e. lipids, proteins and nucleic acid and help to 
distinguish between different tissue types (IU. Rehman et al., 2012). In this study, we 
have analysed 3D tissue engineered models of normal, dysplastic and cancerous oral 
mucosa using Raman spectroscopy to determine the potential of the technique to 
distinguish normal oral mucosa from pre-malignant and cancerous oral mucosa.  
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2. Materials and Methods 
All materials used in this study were purchased from Sigma-Aldrich (Poole, Dorset, UK) 
unless otherwise stated and used as of the manufacturers’ instructions.  
2.1 Cell Culture  
The following cells were used in this study: normal oral fibroblasts (NOF) and 
keratinocytes (NOK) (ethical approval number 09/H1308/66) isolated as previously 
described (Colley et al., 2011). DOK (ECACC, Health Protection Agency Culture 
Collections, Salisbury, UK) derived from a dysplastic oral lesion isolated from the dorsal 
tongue of a 57-year-old male (Chang et al., 1992). D19 and D20 (generously provided 
by Dr. Keith Hunter, School of Clinical Dentistry, University of Sheffield) were derived 
from lateral tongue dysplasia (McGregor et al., 2002, McGregor et al., 1997). The head 
and neck squamous cell carcinoma (HNSCC) cell lines Cal27 and SCC4 (American Tissue 
Culture Collection, Manassas, VA, USA) were both isolated from SCC of the tongue 
(Jiang et al., 2009). FaDu (LGC Promochem, Middlesex, UK) were derived from a 
hypopharyngeal SCC (Rangan, 1972). NOK, D19 and D20 were cultured in Green’s 
media as previously described (Colley et al., 2011). Cal27 and DOK were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal calf serum 
(FCS) (v/v). Cell culture medium for DOK was supplemented with 0.5 μg/ml 
hydrocortisone. FaDu cells were cultured in RPMI-1640 supplemented with 10% FCS 
(v/v) and 100 IU /ml penicillin and 100 μg/ml streptomycin. SCC4 cells were cultured in 
DMEM:Ham’s F12 (1:1), 10% FCS (v/v), 100 IU /ml penicillin, 100 μg/ml streptomycin 
and 0.5 μg/ml hydrocortisone. Media was changed every 2-3 days.  
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2.2. 3D Tissue Engineered Models of the Oral Mucosa 
Tissue engineered models of the oral mucosa were generated as previously described 
(Colley et al., 2011). Briefly, de-epidermised dermis (DED) was prepared from cadaveric 
skin (EuroSkin Bank, Beverwijk, Netherlands). The skin was decelluarised by incubating 
in 1M NaCl at 37°C for 24 hours before carefully scraping the dermis to remove the 
epithelium. Processed DED was stored in DMEM at 4°C until use. To produce the tissue 
engineered models processed DED was cut into 2 cm
2
 squares and placed into a well of 
a 6 well plate. A chamfered surgical stainless steel ring (8 mm internal diameter) was 
placed onto the DED and gentle pressure applied to create a liquid tight seal. To 
generate cancer or dysplastic models, HNSCC (Cal27, SCC4, FaDu) or dysplastic cells 
(DOK, D19 and D20) were seeded within the stainless steel rings (2.5x10
5
) in co-culture 
with NOF (5x10
5
). To generate normal oral mucosa models, NOF (5x10
5
) and NOK 
(1x10
6
) were seeded within the stainless steel rings. After three days all models were 
raised to an air to liquid interface (ALI) before culturing for a further 14 days. Media 
was changed 2-3 times per week. 
2.3. Histological analysis 
At 14 days mucosal models were fixed in 10 % buffered formalin for at least 24 hours 
before histological processing using a Leica TP1020 bench top processor (Leica 
microsystems, Milton Keynes, UK). Samples were paraffin wax embedded and two 
sequential sections of 4 µm and 20 µm thicknesses cut using a manual rotary 
microtome (Leica microsystems, Milton Keynes UK) and then mounted onto 
SuperFrost® Plus glass slides (Thermo Fisher Scientific, MA, USA). Four µm sections 
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were stained with hematoxylin and eosin (H&E) using a Shandon linear staining 
machine (Thermo Fisher Scientific, MA, USA). Twenty µm thick sections were cut and 
de-waxed according to the method of Mian et al (2014). Briefly, samples were placed 
in xylene for 30 minutes followed by immersion in 50%, 70% and 100% ethanol for 5 
minutes each before Raman analysis (Mian et al., 2014).  
2.4. Spectroscopic instrumentation and measurements 
Raman spectra were recorded using a DXR Raman microscopic system (Thermo Fisher 
Scientific, MA, USA). The system was equipped with an Olympus BX51 optical 
microscope and a 532 nm diode-pumped solid-state laser excitation source. A 50X long 
working distance objective was used to focus the excitation laser beam to a spot size 
of 1.1 µm on the sample tissues with a laser power of 10 mW. The allowed spectral 
range was adjusted for 600 cm
-1
 to 3400 cm
-1
, with an estimated spectral resolution of 
5.5 - 8.3 cm
-1
.
 
Exposure time was set to 30 seconds and 5 sample exposures were 
accumulated to improve the signal to noise ratio. A new location of the tissue was 
exposed for each spectra acquisition. The spectra obtained were analysed and 
processed using OMNIC Atlµs™ software suit (Thermo Fisher Scientific, MA, USA).  
2.5. Raman Data Processing 
Raman data from the region 600 cm
-1
 to 3400 cm
-1
 was analysed. Spectra were 
collected from three different models of tissue-engineered normal, dysplastic and 
cancerous oral mucosa. A total of 225 spectra were collected for this study (D20 = 19, 
DOK = 20, D19 = 30, Cal27 = 55, SCC4 = 51, FaDu = 45 and normal oral mucosa NOM = 
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35). Additional spectra were collected from thick cancer epithelia in order to acquire 
maximum biochemical information. Raman data was collected within the epithelia. A 
mean spectrum for each of the samples was produced for the purpose of evaluation 
and comparison. Smoothing and baseline correction for the spectra was performed 
using OMNIC Atlµs™ software suit (Thermo Scientific, Madison, WI, USA). 
2.6. Data Analysis 
Both univariate and multivariate data analysis approaches were employed. Peak height 
analysis was performed over vital contributions from phenylalanine, tryptophan, 
nucleic acid, amide I and amide II using OMNIC Atlµs™ software suit. Chemo-metric 
methods were used to quantify the spectral differences of various groups present in 
the data. These methods were performed over Unscrambler X 10.2 software, 
purchased from Camo software (Oslo, Norway).  Principal component analysis (PCA) 
was performed over the complete spectral range (600 cm
-1 
– 3400cm
-1
), amide I (1550 
cm
-1 
- 1750 cm
-1
) and amide III (1200 cm
-1 
- 1400 cm
-1
) regions of normal, dysplastic and 
cancerous data set. The maximum variance between the data was observed within 
first three principal components (PC’s). Cluster analysis (CA) was performed over full 
spectral range (600 - 3400  cm
-1
) by Ward’s method using squared Euclidean distance. 
Linear Discriminant Analysis (LDA) was also performed over the entire spectral range 
(600- 3400 cm
-1
). Pre-processing comprised of baseline correction and Unit Vector 
Normalisation. 4 samples from each group were left out at each pass for prediction 
until a total number of 20 spectra were predicted.  
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3. Results and discussion 
3.1. Histological classification 
Dysplastic oral lesions and their malignant progression are currently diagnosed by 
microscopic evaluation of cytological and architectural changes within the tissue yet it 
is well acknowledged that evaluation of lesions is subjective with considerable inter- 
and intra-observer variation (Speight et al., 2015). Furthermore currently there are no 
clinically used molecular biomarkers to assist pathologists in the prediction of 
malignant transformation in oral dysplastic lesions (Speight, 2007). These limitations 
have led to an increase in research into spectroscopy techniques as potential 
diagnostic tools. Raman spectroscopy is capable of providing real-time, non-invasive, 
biochemical information of tissues and could be used as an adjutant to current 
histopathological evaluation (Stone et al., 2004). 3D tissue-engineered models of 
normal, dysplastic and cancerous oral mucosa were generated and subject to routine 
H&E staining for evaluation. Histological analysis of tissue-engineered normal oral 
mucosa models revealed a stratified epithelium and a fibroblast-populated dermis 
closely resembling native oral mucosa (Fig. 1a-c). Models produced using dysplastic cell 
lines (DOK, D19 and D20) produced an epithelium histologically typical of dysplastic 
lesions with bulbous rete processes, abnormal cytological changes including the 
presence of mitotic figures in the upper epithelial layers and abnormal keratinocyte 
maturation (Fig. 1d-f). Oral cancer models generated using HNSCC cell lines (Cal27, 
FaDu and SCC4) showed typical features common to the pathology of cancerous 
transformation with abnormal epithelial maturation, resulting in a disordered and thick 
Page 9 of 31
http://mc.manuscriptcentral.com/term
Journal of Tissue Engineering and Regenerative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
10 
 
mucosal epithelium resembling malignant transformation typically seen in vivo 
although not yet invasive into the underlying connective tissue (Fig. 1g-i).  
 
3.2 Raman spectral analysis 
Raman spectra were obtained from 20 µm sections of normal, dysplastic and 
cancerous oral mucosal models. The averaged spectra are presented in Figure 2. 
Spectral differences are evident in both the fingerprint (600 cm
-1
 to 1800 cm
-1
) and 
high wavenumber compartments (2800 cm
-1
 to 3400 cm
-1
) with Raman peaks 
identified attributed to differences in functional groups and biochemical variations 
including the abundance of proteins, lipids and nucleic acids. Due to the complex 
nature of biological tissues Raman peak frequencies often overlap making it difficult to 
assign a particular molecule or single biochemical entity. However, it has been 
identified that certain biochemical components can produce relatively sharp and 
characteristic bands that can be used to highlight dissimilarities between different 
tissue types (Devpura et al., 2012).  
Noticeable features of normal oral mucosa spectrum include a sharp C=C lipid stretch 
at 1653 cm
-1
 (amide I), no prominent contributions at 1245 cm
-1
 (amide III) and 2881 
cm
-1
 (lipids) which are attributed to CH2 wagging and CH2 asymmetric stretch, 
respectively (Fig. 2a). Raman peaks observed in the spectra from dysplastic and oral 
cancer models represent amide I at 1667 cm
-1 
(DOK, D19, FaDu and SCC4), CH2 bending 
at 1447 cm
-1
, broad peaks of amide III between 1300-1200 cm
-1
 and a sharp 
phenylalanine peak at 1003 cm
-1
, all of which signify a major involvement from 
proteins (Movasaghi et al., 2007, Malini et al., 2006)
 
(Fig. 2b-c).  
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In biological tissues broader peaks indicate protein dominance as compared to narrow 
peaks which indicate lipid dominancy. The characteristic peaks observed in the 
spectrum from tissue-engineered normal oral mucosa models can largely be assigned 
to tissue lipids with a minimum contribution from protein (Devpura et al., 2012, 
Movasaghi et al., 2007), consistent with reports that Raman spectra of normal oral 
tissues generally arise from the surface lipid bilayer and hence give rise to lipid 
dominated spectrum (Venkatakrishna et al., 2001, Krishna et al., 2004). In contrast 
cancerous tissues are characterized by large amounts of surface proteins, which 
provide a protein dominated spectrum, as observed here, and forms the basis of 
distinguishing between normal and malignant tissues (IU. Rehman et al., 2012, Malini 
et al., 2006).  
In the amide I region normal, D20 and Cal27 models show a shift from 1667 cm
-1
 to 
1653 cm
-1
,
 
which differentiates them from the rest of the dysplastic and cancerous 
tissues, whilst a moderate broadening of the same peak differentiates these models 
from tissue-engineered normal oral mucosa models (Fig. 2a-b). Furthermore, spectral 
variations at the amide I region also separates D20 from D19 and DOK as well as Cal27 
from FaDu and SCC4 (Fig. 2c). A sharp but weak peak is observed at 1295 cm
-1
 (amide 
III) only in the spectra of D19 and SCC4 which can be assigned to CH2 deformation 
(Movasaghi et al., 2007)
 
(Fig. 2c).  
A prominent peak at 1100 cm
-1 
is noticeable in the Cal27 spectrum and associated with 
nucleic acid PO2
-
 or C-N stretch which discriminates Cal27 from normal, dysplastic and 
the other two cancer models (Fig. 2b-c). 
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Peak at 2881 cm
-1
 is an assignment of CH2 asymmetric stretch of lipids which is absent 
in the spectra of normal, D20 and FaDu models (Fig. 2a-b). A unique shift of the peak is 
also observed at 2937 cm-1 in DOK spectra, attributed to CH2 asymmetric stretch, 
whereas in the rest of the normal, dysplastic and cancer tissue spectra the CH2 
asymmetric stretch was observed at 2932 cm-1. This peak clearly separates DOK from 
all other models (Fig. 2a and c).  
Spectral variations particularly at the amide I, amide III and high wavenumber 
compartment clearly distinguish normal models from D19 and DOK whilst D20 appears 
more similar to NOM in these regions. A narrow band was noticed in the amide I 
region (1653 cm-1) in normal and D20 tissue spectra which was broader and shifted to 
1667 cm
-1
 in the spectra of D19 and DOK, hence differentiating between them. A broad 
peak centered at 1667 cm-1 was evident in the FaDu model spectra, separating it from 
normal, dysplastic and the other cancer models. 
The band at the 642 cm
-1
 is associated with C-C stretching and twisting modes of 
proteins (tyrosine) (Devpura et al., 2011). The bands at 724 cm
-1
 and 780 cm
-1
 regions 
are an assignment of C-N nucleotide peak or lipid/DNA (Devpura et al., 2011) and ring 
breathing mode of DNA/Uracil, respectively. Whilst the band assignment at 828 cm
-1
 
can be attributed to tyrosine/phosphodiester (Devpura et al., 2011) or O-P-O backbone 
stretching of DNA (Su et al., 2012). In addition to altered levels of proteins and lipids, 
the biochemistry of cancer progression can also be linked with abnormal nucleic acid 
synthesis and metabolism (Heimann et al., 1991, DeBerardinis et al., 2008). In the 
spectra presented here at we also observe increased levels of DNA/Uracil (780 cm
-1
)
 
in 
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the cancer models, and to a lesser extent in the dysplastic models, compared to 
normal tissue. Specifically Cal27 models show a broad and intense peak at 1100 cm
-1
 
associated with nucleic acid PO2
-
 or C-N stretch. Changes in the relative intensity as 
well as a shift of these peaks can be related to altered levels of nucleic acids in 
malignancy (Manoharan et al., 1996, Rehman et al., 2007, Valdés et al., 2014, Huang et 
al., 2003).   
In the cancer models an increase in the intensity of the peak at the band 1582 cm-1 
was observed and assigned to C=C bending of phenylalanine, tryptophan and tyrosine 
(Fig. 2b) (Su et al., 2012, Movasaghi et al., 2007, IU. Rehman et al., 2012). Previous 
studies have linked increased levels of tryptophan to malignant tissue when compared 
to normal tissue (Devpura et al., 2012),(Tankiewicz et al., 2006). Here, we report a 
similar pattern for tryptophan from the tissue-engineered models with the peak 
attributed to tryptophan, observed at 1582 cm
-1
 (Devpura et al., 2012, Movasaghi et 
al., 2007), showing a significant increase in intensity as the tissue changes from normal 
to malignant. Tryptophan is an essential amino acid required for different metabolic 
processes and is important for rapidly dividing malignant cells (Tankiewicz et al., 2006) 
which might indicate the reason why it is more abundant in cancerous tissue.   
In this study buccal derived keratinocytes were used to generate normal oral mucosal 
models whilst all the dysplastic and HNC models were generated from cell lines 
derived from the tongue with the exception of the FaDu cell line which is derived from 
a hypopharyngeal squamous cell carcinoma. Previously studies have found that Raman 
spectroscopy is able to discriminate between oral mucosa derived from different 
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anatomical locations within the oral cavity (Bergholt et al., 2012) and may suggest why 
models constructed using the FaDu cell line display unique spectral features in the 
amide I, amide III and lipid regions, differentiating them from all of the other models 
(fig 2b-c). 
3.3. Principal component analysis  
The spectral variations between different tissue types can be understood by using 
chemometric analysis methods that enable interpretation of spectral differences in 
relation to biochemical changes. PCA was performed over two spectral ranges; amide I 
(1515 cm
-1 
- 1770 cm
-1
) and amide III (1220 cm
-1 
- 1300 cm
-1
). A comparison was made 
between normal and dysplastic (fig3a), normal and cancer (fig3b) and dysplastic and 
cancer (fig.3c).  
The amide I band shows favorable separation of normal oral mucosa models from all 
dysplastic models; PC1 separates normal models from D19 and DOK whilst PC2 splits 
D20 from the normal models (Fig. 3a). However, D19 and DOK models continue to 
cluster together up to PC8 accounting for 99.8% of the variance (data not shown). By 
comparison, differences within the dysplastic groups appear to be much greater in the 
amide III region and the scores plot for this region shows good separation between all 
groups (Fig. 3a). Whilst the clusters are more widely spread, loadings plots for PC1 and 
PC2 (data not shown) suggest the contrast in the 1295 cm
-1
 lipid peak and contribution 
from intensity of the 1220 - 1270 cm
-1
 band to be a major influence. PCA demonstrates 
that tissue-engineered normal oral mucosa models can be discriminated from 
dysplastic models using these regions. Again, D20 showed more similarities with 
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normal tissues, with their clusters forming close to each other as compared to D19 and 
DOK. This suggests that biochemical characteristics of D20 are more similar to normal 
tissue compared to D19 and DOK. Furthermore, the separation of D19 from DOK in the 
amide III region suggests that each of the dysplastic models have compositional 
differences. Though all models are derived from dysplastic cell lines the analysis 
indicates separate and disparate behavior by each of the different cell types and may 
be attributed to patient variability or different stages of dysplasia (mild, moderate or 
severe).  
Within the normal and HNC models (Fig. 3b), the sample groups can be well 
discriminated using PCA. In the amide I model, PC1 separates FaDu and SCC4, whereas 
PC2 suggests these two cancer groups also express some similarities. Normal oral 
models and Cal27 show similar differences with respect to variations explained by PC2. 
In the amide III model, PC1 and PC2, accounting for 98% of the variance, discriminates 
FaDu from normal oral models as well as the other cancer models. The corresponding 
loadings plot to PC1 suggests positive loadings for the 1220-1270 cm
-1
 band relative to 
the 1270-1320 cm
-1
 in FaDu compared to other models. Amide III of the normal and 
cancer PCA plot differentiated FaDu from the rest of cancers as well as from normal 
models reconfirming that differences in spectra from various intra-oral locations needs 
to be taken into consideration. Tight cluster formations were also observed for SCC4 
and Cal27, which were separated both from each other and from normal tissue.  
Differentiation between dysplastic lesions and cancerous tissue and predicting 
malignant transformation can be most challenging in terms of diagnosis. Analysis of 
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the amide I and III regions gave encouraging separation of D20 (dysplasia) from the 
cancer groups whereas specifically in the amide III region DOK was discriminated from 
cancer models (Fig. 3c). The PCA also highlights the disparity that exists within tissues 
of the same subtype of D19 (dysplasia) and FaDu (Cancer). The clear separation 
between and within dysplastic and cancer lines suggests substantial differences in the 
biochemical composition of the tissue (Kamath and Mahato, 2007).   
 
3.4. Cluster analysis 
Cluster analysis was performed over the complete spectral range (600-3400 cm
-1
). 
Between the normal and dysplastic tissue-engineered models two main clusters were 
formed; one exclusively containing all of the dysplastic models with a separation 
cluster for the normal models (fig. 4a).  Cluster analysis for normal and cancer models 
revealed that the HNC FaDu is distinct to normal oral mucosa as well as the two other 
HNC models whilst Cal27 is equally distant to NOM as to SCC4 (fig. 4b).  
Figure 4c and 4d show cluster analysis of dysplastic and cancer models and all models 
respectively. Whilst each of the different tissues form well defined clusters, the 
partitioning does not create main subgroups for normal, dysplastic and cancer 
samples. D19 appears closer to SCC4 and FaDu than to the other dysplastic models. 
Dysplastic models generated using the DOK cell line shows the least inner group 
variability on the relative distance scale which suggests the tissue is more 
homogeneous compared to the rest.  
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Cluster analysis formed on the basis of molecular differences between the data set 
showed separate branches in the dendogram for normal, dysplastic and cancer tissue 
models as importantly each subtype was grouped separately in the main branch. Both 
the dysplastic and cancer revealed discrete subsets representing each of the six cell 
types used independently and suggests a high sensitivity of the technique for the 
identification of different subtypes.  This partitioning indicates that the biochemical 
variations present within dysplastic and cancer tissues could be identified and 
clustered separately (Bigio et al., 2000) (Fig. 4c and d). 
3.5. Linear discriminant analysis  
Tissue sections from normal, dysplastic and cancer models were blinded and subject to 
linear discriminant analysis (LDA) to test for the specificity and sensitivity of Raman 
spectroscopy to discriminate and thereby correctly classify tissue samples as normal, 
dysplastic or cancer. LDA predictions of normal versus cancer classified 14 out of the 
20 normal mucosa models correctly with 6 misclassified as cancer; giving an overall 
specificity of 70%. Within the same comparison all cancerous models were classed 
correctly with a sensitivity of 100% (fig.5a).  Analysis of dysplastic versus cancer 
classified 54 out of the 60 dysplastic mucosa models correctly, 6 were misclassified as 
cancer resulting in a sensitivity of 90%. 98% sensitivity was achieved for cancer models 
(fig.5b).  
Raman spectroscopy predictions of blinded samples against known models of normal, 
dysplastic or cancer gave encouraging results with a high percentage of accuracy in 
categorising tissues. Comparison between all types of models predicted normal models 
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with a specificity of 75%.  Out of 60 dysplastic mucosa models tested 54 were 
predicted correctly with 6 misclassified as cancers with a sensitivity of 90%. 59 models 
were predicted correctly as cancer with only one sample misclassified as dysplastic 
giving a sensitivity of 98% (fig. 5c).  
LDA was also completed to test for sensitivity and specificity of Raman spectroscopic 
discrimination of blinded samples and its ability to correctly classify original cell type 
(Fig.6a). 100% sensitivity and specificity for normal and cancerous models was 
achieved. Furthermore, not only were normal models successfully discriminated from 
cancer models but also cancer models were successfully separated from one another 
with 100% sensitivity (fig. 6a).  
Analysis between different dysplastic and cancer models predicted 100% sensitivity to 
D19, Cal27 and SCC4 models and only a small percentage of misclassifications were 
seen between FaDu, D20 and DOK with a sensitivity of 70%, 85% and 90% respectively 
(fig. 6b).  
These findings are consistent with other reports (Singh et al., 2012, Stone et al., 2004). 
Malini et al. (2006) investigated the ability to discriminate between normal and 
cancerous tissue but also extended their data set to include inflammatory and 
premalignant lesions. PCA results concluded that it was possible to separate normal 
from cancer but poor discrimination was recorded amongst abnormal tissues (Malini 
et al., 2006). Here, we observed that Raman spectroscopy showed 100% sensitivity and 
specificity between normal and all HNC models and with a very high level of 
discrimination in identifying between subpopulations of dysplastic and cancer cells. 
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These results indicate that Raman spectroscopy might be sensitive enough to 
discriminate between cancer sub types and when coupled with multivariate data 
analysis techniques have the potential to become a powerful tool to classify different 
grades, stages or types of tumours. 
4. Conclusion 
Currently surgical excision and histopathological evaluation of a suspicious lesion is the 
gold standard for diagnosis of HNC, however it is associated with a number of 
limitations including it being invasive, creating time delays, causing anxiety to the 
patients and misdiagnosis due to high inter and intra-observer variability. Raman 
spectroscopy is an optical technique with the ability to extract molecular level 
information to help determine the functional groups present in a tissue and the 
molecular conformations of tissue constituents. Here we have shown that differences 
in peak intensities can be analysed and attributed to cytological changes caused by 
variations in lipid, protein and nucleic acid contents in cells as malignant 
transformation occurs. Results obtained in this study demonstrate that Raman 
spectroscopy not only has the potential to differentiate between normal, pre-
malignant and cancerous tissue models but could also be sensitive enough to detect 
subtypes of dysplasia or cancer on the basis of their sub-cellular differences. In the 
future it would be interesting to co-relate these findings with ex vivo and in vivo results 
to improve clinical diagnostic outcomes.   
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Figure Legends: 
Figure 1: Haematoxylin and eosin stained sections of tissue-engineered oral mucosa. 
a-c) Normal oral mucosa, d-f) dysplastic oral mucosa, DOK, D19 and D20, respectively. 
g-i) Cancerous oral mucosa Cal27, SCC4 and FaDu, respectively. Yellow boxes indicate 
collection points for spectral data on parallel 20 µm sections.  Scale bar = 100 µm.  
 
Figure 2: Average spectra of tissue engineered mucosa models. a) Normal oral 
mucosa (NOM) and dysplastic oral mucosa models, (D20, D19 and DOK), b) NOM and 
cancerous oral mucosa models (SCC4, FaDu and Cal27) and c) cancerous and dysplastic 
oral mucosa models (SCC4, FaDu, Cal27, D20, D19 and DOK). 
 
Figure 3: Principal component analysis plots. PCA and 3D plots for the amide I and 
amide III spectra range for a) normal versus dysplastic, b) normal versus cancer and c) 
normal versus dysplastic.  
 
Figure 4: Cluster analysis of the full spectral range. a) Normal and dysplastic, b) 
normal and cancer, c) dysplastic and cancer and d) normal, dysplastic and cancer. 
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Figure 5: Final linear discriminant analysis predictions for all unknown tissue 
engineered models in the broad tissue state. a) Normal and cancer, b) dysplastic and 
cancer and c) normal, dysplastic and cancer. 
Figure 6: Final linear discriminant analysis predictions for all unknown tissue 
engineered models by cellular subtype. a) Normal (NOM), and cancer tissue-
engineered models (Cal27, SCC4 and FaDu) and b) dysplastic (D19, D20, DOK) and 
cancer tissue-engineered models (Cal27, SCC4 and FaDu). 
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Figure 1: Haematoxylin and eosin stained sections of tissueengineered oral mucosa. ac) Normal oral 
mucosa, df) dysplastic oral mucosa, DOK, D19 and D20, respectively. gi) Cancerous oral mucosa Cal27, 
SCC4 and FaDu, respectively. Yellow boxes indicate collection points for spectral data on parallel 20 µm 
sections.  Scale bar = 100 µm.  
254x190mm (96 x 96 DPI)  


Page 26 of 31
http://mc.manuscriptcentral.com/term
Journal of Tissue Engineering and Regenerative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Figure 	

 !"#$%&&'
&(%&&'&( !"
#
)'*!" "+*"+,-
 
 
Page 27 of 31
http://mc.manuscriptcentral.com/term
Journal of Tissue Engineering and Regenerative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review



Figure 	


 
!"#$%&'(")$")



Page 28 of 31
http://mc.manuscriptcentral.com/term
Journal of Tissue Engineering and Regenerative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review



	


 !"#!$!$%&'


Page 29 of 31
http://mc.manuscriptcentral.com/term
Journal of Tissue Engineering and Regenerative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review



	





















 !"#$"% "%&'(


Page 30 of 31
http://mc.manuscriptcentral.com/term
Journal of Tissue Engineering and Regenerative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review



	













 

!"#$!!%
&

&'(&")&*

 

!"#$!!%
&
"+%,'()(,(&-.


Page 31 of 31
http://mc.manuscriptcentral.com/term
Journal of Tissue Engineering and Regenerative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
